173 related articles for article (PubMed ID: 16275079)
1. 4-substituted cyclohexyl sulfones as potent, orally active gamma-secretase inhibitors.
Churcher I; Beher D; Best JD; Castro JL; Clarke EE; Gentry A; Harrison T; Hitzel L; Kay E; Kerrad S; Lewis HD; Morentin-Gutierrez P; Mortishire-Smith R; Oakley PJ; Reilly M; Shaw DE; Shearman MS; Teall MR; Williams S; Wrigley JD
Bioorg Med Chem Lett; 2006 Jan; 16(2):280-4. PubMed ID: 16275079
[TBL] [Abstract][Full Text] [Related]
2. 3,4-Fused cyclohexyl sulfones as gamma-secretase inhibitors.
Shaw D; Best J; Dinnell K; Nadin A; Shearman M; Pattison C; Peachey J; Reilly M; Williams B; Wrigley J; Harrison T
Bioorg Med Chem Lett; 2006 Jun; 16(11):3073-7. PubMed ID: 16617016
[TBL] [Abstract][Full Text] [Related]
3. 3-Substituted gem-cyclohexane sulfone based gamma-secretase inhibitors for Alzheimer's disease: conformational analysis and biological activity.
Jelley RA; Elliott J; Gibson KR; Harrison T; Beher D; Clarke EE; Lewis HD; Shearman M; Wrigley JD
Bioorg Med Chem Lett; 2006 Jul; 16(14):3839-42. PubMed ID: 16682202
[TBL] [Abstract][Full Text] [Related]
4. Reductions in beta-amyloid concentrations in vivo by the gamma-secretase inhibitors BMS-289948 and BMS-299897.
Anderson JJ; Holtz G; Baskin PP; Turner M; Rowe B; Wang B; Kounnas MZ; Lamb BT; Barten D; Felsenstein K; McDonald I; Srinivasan K; Munoz B; Wagner SL
Biochem Pharmacol; 2005 Feb; 69(4):689-98. PubMed ID: 15670587
[TBL] [Abstract][Full Text] [Related]
5. Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo.
Hussain I; Hawkins J; Harrison D; Hille C; Wayne G; Cutler L; Buck T; Walter D; Demont E; Howes C; Naylor A; Jeffrey P; Gonzalez MI; Dingwall C; Michel A; Redshaw S; Davis JB
J Neurochem; 2007 Feb; 100(3):802-9. PubMed ID: 17156133
[TBL] [Abstract][Full Text] [Related]
6. P-glycoprotein efflux and other factors limit brain amyloid beta reduction by beta-site amyloid precursor protein-cleaving enzyme 1 inhibitors in mice.
Meredith JE; Thompson LA; Toyn JH; Marcin L; Barten DM; Marcinkeviciene J; Kopcho L; Kim Y; Lin A; Guss V; Burton C; Iben L; Polson C; Cantone J; Ford M; Drexler D; Fiedler T; Lentz KA; Grace JE; Kolb J; Corsa J; Pierdomenico M; Jones K; Olson RE; Macor JE; Albright CF
J Pharmacol Exp Ther; 2008 Aug; 326(2):502-13. PubMed ID: 18499745
[TBL] [Abstract][Full Text] [Related]
7. The novel beta-secretase inhibitor KMI-429 reduces amyloid beta peptide production in amyloid precursor protein transgenic and wild-type mice.
Asai M; Hattori C; Iwata N; Saido TC; Sasagawa N; Szabó B; Hashimoto Y; Maruyama K; Tanuma S; Kiso Y; Ishiura S
J Neurochem; 2006 Jan; 96(2):533-40. PubMed ID: 16336629
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and SAR study of tricyclic sulfones as γ-secretase inhibitors: C-6 and C-8 positions.
Su J; Tang H; McKittrick BA; Xu R; Clader JW; Greenlee WJ; Hyde L; Zhang L
Bioorg Med Chem Lett; 2011 Jun; 21(11):3447-51. PubMed ID: 21515050
[TBL] [Abstract][Full Text] [Related]
9. Aryl sulfones: a new class of gamma-secretase inhibitors.
Teall M; Oakley P; Harrison T; Shaw D; Kay E; Elliott J; Gerhard U; Castro JL; Shearman M; Ball RG; Tsou NN
Bioorg Med Chem Lett; 2005 May; 15(10):2685-8. PubMed ID: 15863342
[TBL] [Abstract][Full Text] [Related]
10. Ex vivo occupancy of gamma-secretase inhibitors correlates with brain beta-amyloid peptide reduction in Tg2576 mice.
Goldstein ME; Cao Y; Fiedler T; Toyn J; Iben L; Barten DM; Pierdomenico M; Corsa J; Prasad CV; Olson RE; Li YW; Zaczek R; Albright CF
J Pharmacol Exp Ther; 2007 Oct; 323(1):102-8. PubMed ID: 17640949
[TBL] [Abstract][Full Text] [Related]
11. Molecular-modeling based design, synthesis, and activity of substituted piperidines as gamma-secretase inhibitors.
Gundersen E; Fan K; Haas K; Huryn D; Steven Jacobsen J; Kreft A; Martone R; Mayer S; Sonnenberg-Reines J; Sun SC; Zhou H
Bioorg Med Chem Lett; 2005 Apr; 15(7):1891-4. PubMed ID: 15780628
[TBL] [Abstract][Full Text] [Related]
12. Tricyclic sulfones as orally active gamma-secretase inhibitors: synthesis and structure-activity relationship studies.
Sasikumar TK; Qiang L; Burnett DA; Cole D; Xu R; Li H; Greenlee WJ; Clader J; Zhang L; Hyde L
Bioorg Med Chem Lett; 2010 Jun; 20(12):3632-5. PubMed ID: 20493690
[TBL] [Abstract][Full Text] [Related]
13. Determination of guinea-pig cortical gamma-secretase activity ex vivo following the systemic administration of a gamma-secretase inhibitor.
Grimwood S; Hogg J; Jay MT; Lad AM; Lee V; Murray F; Peachey J; Townend T; Vithlani M; Beher D; Shearman MS; Hutson PH
Neuropharmacology; 2005 Jun; 48(7):1002-11. PubMed ID: 15857627
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of gamma-secretase and BACE1 inhibition on brain Abeta levels in vitro and in vivo.
Elvang AB; Volbracht C; Pedersen LØ; Jensen KG; Karlsson JJ; Larsen SA; Mørk A; Stensbøl TB; Bastlund JF
J Neurochem; 2009 Sep; 110(5):1377-87. PubMed ID: 19519664
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of succinoyl-caprolactam gamma-secretase inhibitors.
Thompson LA; Liauw AY; Ramanjulu MM; Kasireddy-Polam P; Mercer SE; Maduskuie TP; Glicksman M; Roach AH; Meredith JE; Liu RQ; Combs AP; Higaki JN; Cordell B; Seiffert D; Zaczek RC; Robertson DW; Olson RE
Bioorg Med Chem Lett; 2006 May; 16(9):2357-63. PubMed ID: 16473009
[TBL] [Abstract][Full Text] [Related]
16. Quantitative measurement of changes in amyloid-beta(40) in the rat brain and cerebrospinal fluid following treatment with the gamma-secretase inhibitor LY-411575 [N2-[(2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl]-N1-[(7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl]-L-alaninamide].
Best JD; Jay MT; Otu F; Ma J; Nadin A; Ellis S; Lewis HD; Pattison C; Reilly M; Harrison T; Shearman MS; Williamson TL; Atack JR
J Pharmacol Exp Ther; 2005 May; 313(2):902-8. PubMed ID: 15743924
[TBL] [Abstract][Full Text] [Related]
17. In vivo beta-secretase 1 inhibition leads to brain Abeta lowering and increased alpha-secretase processing of amyloid precursor protein without effect on neuregulin-1.
Sankaranarayanan S; Price EA; Wu G; Crouthamel MC; Shi XP; Tugusheva K; Tyler KX; Kahana J; Ellis J; Jin L; Steele T; Stachel S; Coburn C; Simon AJ
J Pharmacol Exp Ther; 2008 Mar; 324(3):957-69. PubMed ID: 18156464
[TBL] [Abstract][Full Text] [Related]
18. Cyclic sulfamide gamma-secretase inhibitors.
Sparey T; Beher D; Best J; Biba M; Castro JL; Clarke E; Hannam J; Harrison T; Lewis H; Madin A; Shearman M; Sohal B; Tsou N; Welch C; Wrigley J
Bioorg Med Chem Lett; 2005 Oct; 15(19):4212-6. PubMed ID: 16054361
[TBL] [Abstract][Full Text] [Related]
19. In vivo inhibition of Abeta production by memapsin 2 (beta-secretase) inhibitors.
Chang WP; Koelsch G; Wong S; Downs D; Da H; Weerasena V; Gordon B; Devasamudram T; Bilcer G; Ghosh AK; Tang J
J Neurochem; 2004 Jun; 89(6):1409-16. PubMed ID: 15189343
[TBL] [Abstract][Full Text] [Related]
20. Tetracyclic sulfones as potent gamma-secretase inhibitors: synthesis and structure-activity relationship studies.
Sasikumar TK; Burnett DA; Asberom T; Wu WL; Bennett C; Cole D; Xu R; Greenlee WJ; Clader J; Zhang L; Hyde L
Bioorg Med Chem Lett; 2010 Jun; 20(12):3645-8. PubMed ID: 20471254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
